Heterogeneity in the Prevalence of High-Risk Human Papillomavirus Infection in Human Immunodeficiency Virus-Negative and Human Immunodeficiency Virus-Positive Men Who Have Sex With Men in West Africa

被引:9
作者
Yaya, Issifou [1 ]
Boyer, Veronique [1 ]
Ehlan, Phyllis Amivi [2 ]
Coulibaly, Alou [3 ]
Agboyibor, Mawuenyegan Kouamivi [4 ]
Traore, Issa [5 ]
Kouame, Malan Jean-Baptiste [6 ]
Maiga, Alassane Kader [3 ]
Kotchi, Ochoh Rachelle [6 ]
Nyasenu, Yawo Tufa [2 ]
Maradan, Gwenaelle [7 ]
Rojas-Castro, Daniela [8 ]
Diallo, Fodie [3 ]
Anoma, Camille [6 ]
Dah, Ter Tiero Elias [1 ,5 ,9 ]
Mensah, Ephrem [4 ]
Keita, Bintou Dembele [3 ]
Spire, Bruno [7 ]
Dagnra, Claver Anoumou [2 ]
Laurent, Christian [1 ]
机构
[1] Univ Montpellier, TransVIHMI, INSERM, IRD, 911,Ave Agropolis BP 64501, F-34394 Montpellier, France
[2] Univ Lome, Fac Sci La Sante, Lab Biol Mol & Immunol, Lome, Togo
[3] ARCAD Sante Plus, Bamako, Mali
[4] Espoir Vie Togo, Lome, Togo
[5] Assoc African Solidarite, Ouagadougou, Burkina Faso
[6] Espace Confiance, Abidjan, Cote Ivoire
[7] Univ Aix Marseille, SESSTIM, INSERM, IRD, Marseille, France
[8] Coalit Plus, Community Res Lab Pantin, Pantin, France
[9] Inst Natl Sante Publ, Ctr Muraz, Bobo Dioulasso, Burkina Faso
关键词
HPV; HIV; MSM; Africa; UNINFECTED MEN; BURDEN;
D O I
10.1093/cid/ciab157
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Men who have sex with men (MSM) are at high risk of human papillomavirus (HPV) infection. We assessed (i) the prevalence of high-risk HPV (HR-HPV) infection and associated factors, and (ii) the prevalence of vaccine-preventable HPV infections in MSM in Burkina Faso, Cote d'Ivoire, Mali, and Togo. Methods. A cross-sectional study was conducted in 2017-2018 among MSM >= 18 years old followed in community-based clinics. HPV infection was investigated in oral and anal samples using the e-BRID system. Factors associated with HR-HPV infection were identified using multivariate logistic regressions. Results. Among 631 participants, 425 were HIV-negative and 206 HIV-positive. HR-HPV prevalence ranged from 9.2% to 34.8% in the former, and 33.3% to 71.0% in the latter, according to the study country. In multivariate analysis, HIV infection (adjusted odds ratio (aOR) 3.61, 95% confidence interval (CI) 2.48-5.27) and study country (4.73, 2.66-8.43 for Mali; 3.12, 1.68-5.80 for Burkina Faso; 3.51, 1.92-6.42 for Togo) were associated with HR-HPV infection. Other associated factors were low educational level, self-defined homosexual identity, and condomless anal sex. The prevalence of infections which can be prevented with bivalent, quadrivalent, and nonavalent vaccines was 5.9, 27.1, and 34.6% in HIV-negative participants, and 18.9, 43.7, and 54.9% in HIV-positive participants, respectively. Conclusions. HR-HPV prevalence was very heterogeneous between the study countries in both HIV-negative and HIV-positive MSM. Vaccine-preventable HPV infections predominated. Vaccination should be proposed to young MSM to reduce the burden of HPV infection in this vulnerable population and their female partners in West Africa.
引用
收藏
页码:2184 / 2192
页数:9
相关论文
共 35 条
  • [1] Bakai Tchaa Abalo, 2016, Pan Afr Med J, V23, P118, DOI 10.11604/pamj.2016.23.118.7492
  • [2] Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
    Bernard, Hans-Ulrich
    Burk, Robert D.
    Chen, Zigui
    van Doorslaer, Koenraad
    zur Hausen, Harald
    de Villiers, Ethel-Michele
    [J]. VIROLOGY, 2010, 401 (01) : 70 - 79
  • [3] HPV Prevalence in Multiple Anatomical Sites among Men Who Have Sex with Men in Peru
    Blas, Magaly M.
    Brown, Brandon
    Menacho, Luis
    Alva, Isaac E.
    Silva-Santisteban, Alfonso
    Carcamo, Cesar
    [J]. PLOS ONE, 2015, 10 (10):
  • [4] Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic
    Bouassa, Ralph-Sydney Mboumba
    Simaleko, Marcel Mbeko
    Camengo, Serge Police
    Mossoro-Kpinde, Christian Diamant
    Veyer, David
    Matta, Mathieu
    Robin, Leman
    Longo, Jean De Dieu
    Gresenguet, Gerard
    Pere, Helene
    Meye, Jean-Francois
    Belec, Laurent
    [J]. PLOS ONE, 2018, 13 (05):
  • [5] Consistent Condom Use Reduces the Genital Human Papillomavirus Burden Among High-Risk Men: The HPV Infection in Men Study
    Campbell, Christine M. Pierce
    Lin, Hui-Yi
    Fulp, William
    Papenfuss, Mary R.
    Salmeron, Jorge J.
    Quiterio, Manuel M.
    Lazcano-Ponce, Eduardo
    Villa, Luisa L.
    Giuliano, Anna R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (03) : 373 - 384
  • [6] Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
    de Martel, Catherine
    Georges, Damien
    Bray, Freddie
    Ferlay, Jacques
    Clifford, Gary M.
    [J]. LANCET GLOBAL HEALTH, 2020, 8 (02): : E180 - E190
  • [7] Worldwide burden of cancer attributable to HPV by site, country and HPV type
    de Martel, Catherine
    Plummer, Martyn
    Vignat, Jerome
    Franceschi, Silvia
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (04) : 664 - 670
  • [8] The Biology and Life-Cycle of Human Papillomaviruses
    Doorbar, John
    Quint, Wim
    Banks, Lawrence
    Bravo, Ignacio G.
    Stoler, Mark
    Broker, Tom R.
    Stanley, Margaret A.
    [J]. VACCINE, 2012, 30 : F55 - F70
  • [9] Anal Human Papillomavirus Infection among MSM Attending University in China: Implications for Vaccination
    Fan, Song
    Li, Peiyang
    Ouyang, Lin
    Yuan, Tanwei
    Gong, Hui
    Ding, Yi
    Luo, Zhenzhou
    Wu, Guohui
    Yu, Maohe
    Zou, Huachun
    [J]. VACCINES, 2020, 8 (02)
  • [10] Prevalence of Human Papillomavirus, Human Immunodeficiency Virus, and Other Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo: A National Cross-sectional Survey
    Ferre, Valentine Marie
    Gbeasor-Komlanvi, Fifonsi A.
    Collin, Gilles
    Dagnra, Anoumou Claver
    Le Hingrat, Quentin
    Jaquet, Antoine
    Salou, Mounerou
    Descamps, Diane
    Charpentier, Charlotte
    Ekouevi, Didier Koumavi
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 69 (06) : 1019 - 1026